We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA SHOULD BROADEN COMPARABILITY PROTOCOL USE, SAY DRUGMAKERS
FDA SHOULD BROADEN COMPARABILITY PROTOCOL USE, SAY DRUGMAKERS
January 5, 2004
The FDA should expand the use of comparability protocols to cover multiple products within a facility rather than limiting the use to document manufacturing changes to specific products, manufacturers told the agency in response to a draft guidance released in September.